• Reference Citation Analysis
  • v
  • v
  • Find an Article
  • Find an Author
Download
Number Citation Analysis
1
Bendayan M, Bonneau C, Delespierre MT, Sais E, Picard F, Alter L, Boitrelle F, Cazabat L. Evaluating the satisfaction and utility of social networks in medical practice and continuing medical education. BMC Med Educ 2024;24:186. [PMID: 38395875 PMCID: PMC10893748 DOI: 10.1186/s12909-024-05149-z] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 12/12/2023] [Accepted: 02/08/2024] [Indexed: 02/25/2024]
2
Casulleras MJ, Barrera JB, Sais E, Hernandez A, Gasusachs M, Carcereny E, Moran T, Vinolas MD, Palmero R, Brenes J, Vilariño N, Ruffinelli J, Fina C, Lorente S, Teule A, Lazaro C, Nadal E. 1272P First results of the early onset lung cancer (EOLUNG) study to characterize genomic alterations using FoundationOne CDx in young patients with non-small cell lung cancer. Ann Oncol 2021. [DOI: 10.1016/j.annonc.2021.08.1874] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]  Open
3
Bosch-Barrera J, Priego N, Puigdemont M, Sais E, Quer N, Izquierdo A, Hernandez A, Cuyàs E, Carbó A, Teixidor E, Verdura S, Garcia D, Roselló A, Garriga V, Pedraza S, Brunet J, Calvo A, Menéndez J, Valiente M. P2.01-49 Targeting STAT3-Positive Reactive Astrocytes with Silibinin in the Therapeutic Landscape of Non-Small-Cell Lung Cancer with Brain Metastases. J Thorac Oncol 2019. [DOI: 10.1016/j.jtho.2019.08.1392] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
4
Angelats L, Campelo RG, Bernabe R, Arriola E, Rocha P, De Juan VC, Sais E, Barba A, Viñolas N, Moreno MG, Vilà L, Juan O, Vilariño N, Cobo M, Domine M, Vazquez S, Coves J, Marse-Fabregat R, Gomez AE, Carcereny E. P1.01-93 Metastases Sites as a Prognostic Factor in a Real-World Multicenter Cohort Study of Spanish ALK-Positive NSCLC Patients (p). J Thorac Oncol 2019. [DOI: 10.1016/j.jtho.2019.08.808] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
5
Angelats L, Garcia Campelo M, Bernabe Caro R, Arriola Aperribay E, Calvo de Juan V, Barba Joaquín A, Vinolas Segarra N, Gil Moreno M, Vilà Martinez L, Juan Vidal O, Vilariño Quintela N, Cobo M, Sais E, Domine Gomez M, Fernandez Nuñez N, Coves Sarto J, Marse Fabregat R, Esteve Gomez A, Rodríguez-Abreu D, Carcereny Costa E. Effect of central nervous system (CNS) metastases in a real-world multicenter cohort study of Spanish ALK-positive non-small cell lung cancer (NSCLC) patients (p). Ann Oncol 2019. [DOI: 10.1093/annonc/mdz063.039] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022]  Open
6
Bosch Barrera J, Ruffinelli J, Carcereny E, Sais E, Verdura S, Cuyàs E, Palmero R, Izquierdo A, Morán T, Nadal E, Menéndez J. P1.13-29 Overall Response Rate of Nintedanib and Docetaxel in Combination with the Nutraceutical Use of Silibinin in Advanced NSCLC. J Thorac Oncol 2018. [DOI: 10.1016/j.jtho.2018.08.886] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022]
7
Barrera JB, Sais E, Verdura S, Cuyas E, Roa D, Hernández A, Izquierdo A, Teixidor E, Carbajal W, Lopez M, Brunet J, Menendez J. P1.03-035 Efficacy of Nintedanib and Docetaxel in Combination with the Nutraceutical Use of Silibinin in Advanced NSCLC. J Thorac Oncol 2017. [DOI: 10.1016/j.jtho.2017.09.839] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
8
Bosch-Barrera J, Sais E, Izquierdo A, Hernández A, Roa D, Cuyas E, Pedraza S, Priego N, Ortuño P, Sánchez G, Cañete N, Roselló A, Soffietti R, Brunet J, Valiente M, Menendez J. Effect of silibinin nutraceutical supplementation in brain metastases of patients with advanced lung cancer. Ann Oncol 2017. [DOI: 10.1093/annonc/mdx366.035] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022]  Open
PrevPage 1 of 1 1Next
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA